» Articles » PMID: 37651428

Identification of People with Low Prevalence Diseases in Administrative Healthcare Records: A Case Study of HIV in British Columbia, Canada

Abstract

Introduction: Case-finding algorithms can be applied to administrative healthcare records to identify people with diseases, including people with HIV (PWH). When supplementing an existing registry of a low prevalence disease, near-perfect specificity helps minimize impacts of adding in algorithm-identified false positive cases. We evaluated the performance of algorithms applied to healthcare records to supplement an HIV registry in British Columbia (BC), Canada.

Methods: We applied algorithms based on HIV-related diagnostic codes to healthcare practitioner and hospitalization records. We evaluated 28 algorithms in a validation sub-sample of 7,124 persons with positive HIV tests (2,817 with a prior negative test) from the STOP HIV/AIDS data linkage-a linkage of healthcare, clinical, and HIV test records for PWH in BC, resembling a disease registry (1996-2020). Algorithms were primarily assessed based on their specificity-derived from this validation sub-sample-and their impact on the estimate of the total number of PWH in BC as of 2020.

Results: In the validation sub-sample, median age at positive HIV test was 37 years (Q1: 30, Q3: 46), 80.1% were men, and 48.9% resided in the Vancouver Coastal Health Authority. For all algorithms, specificity exceeded 97% and sensitivity ranged from 81% to 95%. To supplement the HIV registry, we selected an algorithm with 99.89% (95% CI: 99.76% - 100.00%) specificity and 82.21% (95% CI: 81.26% - 83.16%) sensitivity, requiring five HIV-related healthcare practitioner encounters or two HIV-related hospitalizations within a 12-month window, or one hospitalization with HIV as the most responsible diagnosis. Upon adding PWH identified by this highly-specific algorithm to the registry, 8,774 PWH were present in BC as of March 2020, of whom 333 (3.8%) were algorithm-identified.

Discussion: In the context of an existing low prevalence disease registry, the results of our validation study demonstrate the value of highly-specific case-finding algorithms applied to administrative healthcare records to enhance our ability to estimate the number of PWH living in BC.

Citing Articles

Healthcare utilisation in people living with HIV: the role of substance use, mood/anxiety disorders and unsustained viral suppression - a retrospective cohort study in British Columbia, Canada, 2001-2019.

Shayegi-Nik S, Wang L, Magee C, Li J, Budu M, Kooij K BMJ Open. 2025; 15(3):e088818.

PMID: 40044190 PMC: 11883530. DOI: 10.1136/bmjopen-2024-088818.


Secondary use of routinely collected administrative health data for epidemiologic research: Answering research questions using data collected for a different purpose.

Emerson S, McLinden T, Sereda P, Yonkman A, Trigg J, Peterson S Int J Popul Data Sci. 2024; 9(1):2407.

PMID: 39620116 PMC: 11606632. DOI: 10.23889/ijpds.v9i1.2407.

References
1.
Benchimol E, Guttmann A, Griffiths A, Rabeneck L, Mack D, Brill H . Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009; 58(11):1490-7. DOI: 10.1136/gut.2009.188383. View

2.
Shiff N, Oen K, Rabbani R, Lix L . Validation of administrative case ascertainment algorithms for chronic childhood arthritis in Manitoba, Canada. Rheumatol Int. 2017; 37(9):1575-1584. DOI: 10.1007/s00296-017-3734-1. View

3.
Doiron D, Raina P, Fortier I . Linking Canadian population health data: maximizing the potential of cohort and administrative data. Can J Public Health. 2013; 104(3):e258-61. PMC: 3880355. DOI: 10.17269/cjph.104.3775. View

4.
Goetz M, Hoang T, Kan V, Rimland D, Rodriguez-Barradas M . Development and validation of an algorithm to identify patients newly diagnosed with HIV infection from electronic health records. AIDS Res Hum Retroviruses. 2014; 30(7):626-33. DOI: 10.1089/AID.2013.0287. View

5.
Boulanger V, Schlemmer M, Rossov S, Seebald A, Gavin P . Establishing Patient Registries for Rare Diseases: Rationale and Challenges. Pharmaceut Med. 2020; 34(3):185-190. PMC: 7286934. DOI: 10.1007/s40290-020-00332-1. View